category,datetime,headline,id,image,related,source,summary,url
company,1768414783,JPM26: Edwards Lifesciences targets 10% growth in 2026,138114849,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,EW,Yahoo,Edwards cited broader TAVR treatment populations and ongoing evidence generation as key growth drivers for the new year.,https://finnhub.io/api/news?id=ab7ce53a4fed6a8c6f93709600d41f0ffe5401f19ada2357b22946107b38df27
company,1768395000,Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now?,138111962,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,EW,Yahoo,"EW benefits from strong TAVR and TMTT momentum, but macro pressures and FX headwinds cloud the near-term outlook.",https://finnhub.io/api/news?id=028621b8fa3bb06f5d0e8bd5efc4c1e4ffcd2b3284c15cab949231ad89f35fd3
